Related Experiment Video
Updated: Jan 30, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Antenatal corticosteroid therapy: Historical and scientific basis to improve preterm birth management
Carlos Briceño-Pérez1, Eduardo Reyna-Villasmil2, Paulino Vigil-De-Gracia3
1Department of Obstetrics and Gynecology, University of Zulia, Maracaibo, Venezuela.
Insights
Antenatal corticosteroids (ACS) therapy significantly reduces complications and mortality in premature infants. This evidence-based practice is recommended for women delivering before 34 weeks gestation.
Area of Science:
- Obstetrics and Gynecology
- Neonatology
- Pharmacology
Background:
- Antenatal corticosteroids (ACS) therapy has a well-established historical and scientific foundation.
- Initiated in 1972, its efficacy has been consistently supported by meta-analyses and consensus conferences.
Purpose of the Study:
- To review the historical and scientific basis of antenatal corticosteroids (ACS) therapy.
- To highlight its role in improving the management of preterm birth and reducing infant complications.
Main Methods:
- Literature search of MEDLINE/PubMed and Cochrane Library.
- Utilized keywords such as "ACS", "corticosteroids", "betamethasone", "dexamethasone", and "preterm birth".
Main Results:
- ACS therapy is a crucial evidence-based practice for reducing mortality and complications in premature infants.
- Established benefits include decreased rates of respiratory distress syndrome, intraventricular hemorrhage, and necrotizing enterocolitis.
Conclusions:
- ACS treatment is unequivocally recommended for women delivering before 34 weeks gestation.
- Rescue courses are advised, but multiple, serial, or weekly courses are not.
- ACS is recommended in specific conditions like preterm premature rupture of membranes, multiple pregnancies, severe preeclampsia/HELLP syndrome, and fetal growth restriction.
Objective:
The purpose of this review is to describe the historical and scientific basis of antenatal corticosteroids (ACS) therapy, to improve the management of preterm birth and decreasing rates of respiratory distress syndrome, intraventricular hemorrhage, necrotizing enterocolitis and perinatal mortality in premature infants.
Study Design:
We searched MEDLINE/PubMed electronic database, the Cochrane Library, using medical subheading search words such as "ACS", "corticosteroids", "betamethasone" or "dexamethasone", matching with "preterm birth".
Results:
This practice was initiated by Liggins and Howie in 1972 and is supported by the initial comprehensive meta-analysis of Crowley, Chambers and Keirse, in 1990, the NIH Consensus Development Conference in 1994, the second Consensus Conference to evaluate repeated courses of corticosteroids in 2000 and the practice recommendations of obstetric societies worldwide. ACS therapy before anticipated preterm birth is one of the most important antenatal therapies and an important evidence-based practice for reducing mortality, and decreasing rates of complications in premature infants.
Conclusions:
Today, there is no controversy that women with preterm birth <34 weeks should be ACS treated. Actually, rescue courses are recommended; while multiple, serial, repeated or weekly courses, are not recommended. In any clinical conditions, as preterm premature rupture of membranes, multiple pregnancies, severe preeclampsia/HELLP syndrome and fetal growth restriction; ACS is recommended.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
The Scientific Method
The Scientific Method
Generally, predictions are tested using carefully-designed experiments. Based on the outcome of these...
The Scientific Method
Scientific Laws and Theories
Birth Control Methods

